“In the 21st Century, we don’t need a mission to the moon; we need a mission to the mind.”
In the same room where John F. Kennedy declared his intent to run for president, another Massachusetts senator, Ed Markey (D), made those remarks a few days ago during a briefing by the Personalized Medicine Coalition to highlight precision medicine. Precision medicine seeks to maximize effectiveness by taking into account individual differences in lifestyle, environment and genes.
But the conversation quickly turned to the topic of medical research funding. How much money will go to the National Institutes of Health under the Trump administration?
Research is one of the areas both Republicans and Democrats want to fund, and the president himself has made some comments in favor of innovation and research. But with $54 billion in discretionary funding potentially on the chopping block, that money will have to come from somewhere.
I caught up with Sen. Markey after his remarks, and he told me if the Republicans plan to pass massive tax cuts while building the U.S.-Mexico border wall, increasing defense spending and balancing the budget, “Well, something has to go.”
“You don’t have to be a genius detective to figure out what’s left.”
The next day, Sen. Roy Blunt (R-Mo.) also told me “it would be very hard to get the Senate to do that,” when I asked him to comment on the president’s plan to cut $54 billion.
“I don’t think it’s hard to get the Senate to increase defense dollars. But I think at the cost of other discretionary dollars, that’s a tall order and I think while we need to be focused on defense, we’re going to look at other ways to get that done,” Blunt said after a hearing on medical research.
He paused and was careful in choosing his words. But his position is critical for medical research as he is the chairman of the labor-health panel on the Senate Appropriations Committee—which means he’s taking the lead with ranking member Sen. Patty Murray (D-Wash.) on how a number of health agencies will be funded, including the NIH.
This should be an interesting year for budget talks. I’ll be covering the NIH portion as it unfolds.
Read my full story here.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)